• 1
    Castranova V. Overview of current toxicological knowledge of engineered nanoparticles. J Occup Environ Med 2011; 53 (Suppl 6): S14S17.
  • 2
    Egerton TA, Tooley IR. UV absorption and scattering properties of inorganic-based sunscreens. Int J Cosmet Sci 2012; 34: 117122.
  • 3
    Pflücker F, Hohenberg H, Hölzle E et al. The outermost stratum corneum layer is an effective barrier against dermal uptake of topically applied micronized titanium dioxide. Int J Cosmet Sci 1999; 21: 399411.
  • 4
    Newman MD, Stotland M, Ellis JI. The safety of nanosized particles in titanium dioxide- and zinc oxide-based sunscreens. J Am Acad Dermatol 2009; 61: 685692.
  • 5
    Iavicoli I, Leso V, Fontana L, Bergamaschi A. Toxicological effects of titanium dioxide nanoparticles: a review of in vitro mammalian studies. Eur Rev Med Pharmacol Sci 2011; 15: 481508.
  • 6
    Saquib Q, Al-Khedhairy AA, Siddiqui MA, Abou-Tarboush FM, Azam A, Musarrat J. Titanium dioxide nanoparticles induced cytotoxicity, oxidative stress and DNA damage in human amnion epithelial (WISH) cells. Toxicol In Vitro 2012; 26: 351361.
  • 7
    Yin JJ, Liu J, Ehrenshaft M et al. Phototoxicity of nano titanium dioxides in HaCaT keratinocytes: generation of reactive oxygen species and cell damage. Toxicol Appl Pharmacol 2012; 263: 8188.
  • 8
    Asare N, Instanes C, Sandberg WJ et al. Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology 2012; 291: 6572.
  • 9
    Yazdi AS, Guarda G, Riteau N et al. Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci USA 2010; 107: 1944919454.
  • 10
    Watanabe M, Okada M, Kudo Y et al. Differences in the effects of fibrous and particulate titanium dioxide on alveolar macrophages of Fischer 344 rats. J Toxicol Environ Health A 2002; 65: 10471060.
  • 11
    Hsiao IL, Huang YJ. Effects of various physicochemical characteristics on the toxicities of ZnO and TiO nanoparticles toward human lung epithelial cells. Sci Total Environ 2011; 409: 12191228.
  • 12
    Sabetrasekh R, Tiainen H, Lyngstadaas SP, Reseland J, Haugen H. A novel ultra-porous titanium dioxide ceramic with excellent biocompatibility. J Biomater Appl 2011; 25: 559580.
  • 13
    Liu L, Liu Z, Bai H, Sun DD. Concurrent filtration and solar photocatalytic disinfection/degradation using high-performance Ag/TiO2 nanofiber membrane. Water Res 2012; 46: 11011112.
  • 14
    Kaplan DH, Igyártó BZ, Gaspari AA. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol 2012; 12: 114124.
  • 15
    Gutowska-Owsiak D, Ogg GS. The epidermis as an aduvant. J Invest Dermatol 2012; 132: 940948.
  • 16
    Chiang A, Tudela E, Maibach HI. Percutaneous absorption in diseased skin: an overview. J Appl Toxicol 2012; 32: 537563.
  • 17
    Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med 2011; 365: 13151327.
  • 18
    Mori T, Kabashima K, Yoshiki R et al. Cutaneous hypersensitivities to hapten are controlled by IFN-γ-upregulated keratinocyte Th1 chemokines and IFN-γ-downregulated Langerhans cell Th2 chemokines. J Invest Dermatol 2008; 128: 17191727.
  • 19
    Martinon F. Update on biology: uric acid and the activation of immune and inflammatory cells. Curr Rheumatol Rep 2010; 12: 135141.
  • 20
    Ogura K, Yahiro K, Tsutsuki H et al. Characterization of Cholix toxin-induced apoptosis in HeLa cells. J Biol Chem 2011; 286: 3720737215.
  • 21
    Filewod NC, Pistolic J, Hancock RE. Low concentrations of LL-37 alter IL-8 production by keratinocytes and bronchial epithelial cells in response to proinflammatory stimuli. FEMS Immunol Med Microbiol 2009; 56: 233240.
  • 22
    Nickoloff BJ, Stevens SR. What have we learned in dermatology from the biologic therapies? J Am Acad Dermatol 2006; 54: S143S151.
  • 23
    Paquet P, Piérard GE. Interleukin-6 and the skin. Int Arch Allergy Immunol 1996; 109: 308317.
  • 24
    Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996; 184: 20072012.
  • 25
    Sugita K, Kabashima K, Atarashi K, Shimauchi T, Kobayashi M, Tokura Y. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol 2007; 147: 176183.
  • 26
    Zhang LW, Monteiro-Riviere NA. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci 2009; 110: 138155.
  • 27
    Palomäki J, Välimäki E, Sund J et al. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 2011; 5: 68616870.
  • 28
    Reisetter AC, Stebounova LV, Baltrusaitis J et al. Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J Biol Chem 2011; 286: 2184421852.
  • 29
    Winter M, Beer HD, Hornung V, Krämer U, Schins RP, Förster I. Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells. Nanotoxicology 2011; 5: 326340.
  • 30
    Uratsuji H, Tada Y, Kawashima T et al. P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. J Immunol 2012; 188: 436444.
  • 31
    Xu J, Sagawa Y, Futakuchi M et al. Lack of promoting effect of titanium dioxide particles on ultraviolet B-initiated skin carcinogenesis in rats. Food Chem Toxicol 2011; 49: 12981302.
  • 32
    Sagawa Y, Futakuchi M, Xu J et al. Lack of promoting effect of titanium dioxide particles on chemically-induced skin carcinogenesis in rats and mice. J Toxicol Sci 2012; 37: 317327.